Corrigendum to “The pyrazolo[4,3-c]pyrazole core as a novel and versatile scaffold for developing dual DYRK1A-CLK1 inhibitors targeting key processes of Alzheimer's disease pathology” [Europ. J. Med. Chem. Rep. 12 (2024) 100193]
Titel:
Corrigendum to “The pyrazolo[4,3-c]pyrazole core as a novel and versatile scaffold for developing dual DYRK1A-CLK1 inhibitors targeting key processes of Alzheimer's disease pathology” [Europ. J. Med. Chem. Rep. 12 (2024) 100193]
Auteur:
Bakalakou, Vaia-Argyro Mavroidi, Barbara Kalampaliki, Amalia D. Josselin, Béatrice Bach, Stéphane Skaltsounis, Alexios-Leandros Marakos, Panagiotis Pouli, Nicole Pelecanou, Maria Myrianthopoulos, Vassilios Ruchaud, Sandrine Kostakis, Ioannis K.